PubMed:32471876 JSONTXT 22 Projects

Registries Offer Insights on COVID-19-Cancer Connection. Findings from CCC19 and TERAVOLT suggest that patients with cancer may be more likely to die from COVID-19 than people in the general population. Additional mortality risk factors may include age, performance status, treatment with chemotherapy, and exposure to hydroxychloroquine plus azithromycin.